Chronic Hepatitis B Market Growth Driven by Advancements and Rising Awareness in the US The chronic hepatitis B market is poised for significant growth in the US due to advancements in treatment options and increased awareness about the disease.

Chronic Hepatitis B Market Growth Driven by Advancements and Rising Awareness in the US #United_States #Las_Vegas #Hepatitis_B #Gilead_Sciences #VEMLIDY

Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis - PubMed The results suggest that the presence of anti-EBV antibodies is associated with MRI markers of GM atrophy in MS and with increased loss of brain volume over 3 years.

pubmed.ncbi.nlm.nih.gov/19168469/

So many pieces to this. But without testing I would be full time wheelchair (not awful) but cognitively ruined. On #antivirals #vcv #vemlidy and good #B/Tcelltreatment, some days I have imposter syndrome.

Also: end 🧵

www.sciencedirect.com/science/arti...

I have no clue if this is an absolute causative thing for all with #MS. Or whether it’s comorbid situation for me due to poor viral control genetics and toxic chemical exposure. But because it doesn’t look like #EBV, we aren’t tested. Or it doesn’t look like #HERV - #vemlidy (#TAF) seems better.

It may be something to do with having #MS. I’m aware of quite a number of folks with MS having success with #valacyclovir or #vemlidy.